Regeneron Pharmaceuticals
REGN
$828.10
Share price
-0.42%
Change (1 day)
17.59%
Change (1 year)
Categories
Regeneron Pharmaceuticals (REGN) - P/B ratio
P/B ratio as of September 2023 : 3.76
According to Regeneron Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 3.76.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Regeneron Pharmaceuticals - P/B ratio (from 2001 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 3.47 | -4.19% |
| 2021-12-31 | 3.62 | -22.61% |
| 2020-12-31 | 4.68 | 25.23% |
| 2019-12-31 | 3.73 | -19.69% |
| 2018-12-31 | 4.65 | -29.28% |
| 2017-12-31 | 6.57 | -24.45% |
| 2016-12-31 | 8.70 | -44.02% |
| 2015-12-31 | 15.5 | -5.96% |
| 2014-12-31 | 16.5 | 17.6% |
| 2013-12-31 | 14.1 | 5.17% |
| 2012-12-31 | 13.4 | 26.5% |
| 2011-12-31 | 10.6 | 89.94% |
| 2010-12-31 | 5.56 | 12.52% |
| 2009-12-31 | 4.94 | 41.58% |
| 2008-12-31 | 3.49 | -15.62% |
| 2007-12-31 | 4.14 | -31.72% |
| 2006-12-31 | 6.06 | -23.02% |
| 2005-12-31 | 7.87 | 179.3% |
| 2004-12-31 | 2.82 | -52.54% |
| 2003-12-31 | 5.94 | 5.23% |
| 2002-12-31 | 5.64 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 5.54 | 47.26% | 🇺🇸 USA |
 Novartis NVS | 4.13 | 9.75% | 🇨🇭 Switzerland |
 Amgen AMGN | 21.4 | 469.68% | 🇺🇸 USA |
 Sanofi SNY | 1.75 | -53.56% | 🇫🇷 France |
 Biogen BIIB | 2.61 | -30.58% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -53.8 | -1,530.16% | 🇺🇸 USA |